Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
BACKGROUND:Mass drug administration (MDA) treatment of active trachoma with antibiotic is recommended to be initiated in any district where the prevalence of trachoma inflammation, follicular (TF) is ≥ 10% in children aged 1-9 years, and then to continue for at least three annual rounds before resur...
Saved in:
Main Authors: | Emma Harding-Esch (Author), Mireia Jofre-Bonet (Author), Jaskiran K Dhanjal (Author), Sarah Burr (Author), Tansy Edwards (Author), Martin Holland (Author), Ansumana Sillah (Author), Sheila West (Author), Tom Lietman (Author), Jeremy Keenan (Author), David Mabey (Author), Robin Bailey (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia.
by: Emma M. Harding-Esch, et al.
Published: (2013) -
Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
by: Emma M Harding-Esch, et al.
Published: (2013) -
Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
by: Emma M Harding-Esch, et al.
Published: (2009) -
Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.
by: Tansy Edwards, et al.
Published: (2014) -
Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
by: Matthew J Burton, et al.
Published: (2010)